Oliver Luxxe Assets LLC boosted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,283 shares of the pharmacy operator’s stock after buying an additional 219 shares during the quarter. Oliver Luxxe Assets LLC’s holdings in Walgreens Boots Alliance were worth $727,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Twin Capital Management Inc. lifted its holdings in Walgreens Boots Alliance by 4.3% during the 2nd quarter. Twin Capital Management Inc. now owns 72,100 shares of the pharmacy operator’s stock worth $5,646,000 after buying an additional 2,990 shares in the last quarter. MUFG Americas Holdings Corp lifted its holdings in Walgreens Boots Alliance by 1.1% during the 2nd quarter. MUFG Americas Holdings Corp now owns 158,618 shares of the pharmacy operator’s stock worth $12,421,000 after buying an additional 1,697 shares in the last quarter. Welch Group LLC lifted its holdings in Walgreens Boots Alliance by 122.1% during the 2nd quarter. Welch Group LLC now owns 8,530 shares of the pharmacy operator’s stock worth $668,000 after buying an additional 4,690 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in Walgreens Boots Alliance by 2.1% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,878,613 shares of the pharmacy operator’s stock worth $225,424,000 after buying an additional 60,235 shares in the last quarter. Finally, GAM Holding AG lifted its stake in shares of Walgreens Boots Alliance by 4.0% in the 2nd quarter. GAM Holding AG now owns 114,681 shares of the pharmacy operator’s stock valued at $8,981,000 after purchasing an additional 4,400 shares during the period. 60.14% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance, Inc. (WBA) opened at 67.20 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $67.11 and a 12-month high of $89.69. The firm’s 50-day moving average price is $76.76 and its 200-day moving average price is $80.20. The company has a market cap of $71.91 billion, a PE ratio of 16.97 and a beta of 1.25.

Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase plan on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s management believes its shares are undervalued.

A number of research firms have recently weighed in on WBA. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. Robert W. Baird reissued an “outperform” rating and issued a $80.00 price target (down previously from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday. They noted that the move was a valuation call. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday, July 2nd. Guggenheim reissued a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Finally, Morgan Stanley reissued an “overweight” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two research analysts have rated the stock with a sell rating, six have given a hold rating and fourteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $89.24.

COPYRIGHT VIOLATION WARNING: This report was originally published by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.dailypolitical.com/2017/10/20/oliver-luxxe-assets-llc-boosts-holdings-in-walgreens-boots-alliance-inc-wba.html.

In other news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.50% of the stock is currently owned by corporate insiders.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.